ABSTRACT
The Zr and Co co-substituted Ni0.5Zn0.5Fe2O4 have been synthesized by sol-gel auto combustion method. The XRD patterns provide single phase cubic spinel with ( F d 3 ¯ m ( O h 7 )) space group and extra peaks found in XRD patterns from x = 0.24 to x = 0.4. The experimental lattice parameter is increased from 8.3995Å to 8.4129 Å and the theoretical lattice parameter is increased from 8.3948Å to 8.4130Å with increasing dopant concentration. The substitute ions in place of ferric ions cause the significant changes in all structural parameters. The D.C resistivity is increased from 126597 Ω-cm to 684229 Ω-cm and the drift mobility is decreased from 4.9×10-36 cm2/V-s to 1.88× 10-36cm2/V-s with increasing dopant concentration. The activation energy is decreased from 0.2108 eV to 0.0905 eV with increasing doping concentration. The saturation magnetization is decreased from 71.1559 emu/gm to 28.2405 emu/gm and the net magnetic moment is decreased from 6.3556 Bhor magnetons to 2.5523 Bhor magnetons with increasing dopant concentration. The Y-K angles are increased from 20.0723Ì to 59.4274Ì with increasing dopant concentration. The anisotropy constant has increased from 100 to 351 with increasing dopant concentration. The permeability is decreased from 117 to 19.4524 with increasing dopant concentration.
ABSTRACT
BACKGROUND: Interest in the neuro-cognitive profile of patients with schizophrenia and co-morbid obsessive compulsive disorder (schizo-OCD) is rising in response to reports of high co-morbidity rates. Whereas schizophrenia has been associated with global impairment in a wide range of neuro-cognitive domains, OCD is associated with specific deficits featuring impaired performance on tasks of motor and cognitive inhibition involving frontostriatal neuro-circuitry. METHOD: We compared cognitive function using the CANTAB battery in patients with schizo-OCD (n=12) and a schizophrenia group without OCD symptoms (n=16). The groups were matched for IQ, gender, age, medication, and duration of illness. RESULTS: The schizo-OCD patients made significantly more errors on a task of attentional set-shifting (ID-ED set-shift task). By contrast, no significant differences emerged on the Stockings of Cambridge task, the Cambridge Gamble Task or the Affective Go/NoGo tasks. No correlation emerged between ID-ED performance and severity of schizophrenia, OCD or depressive symptoms, consistent with neurocognitive impairment holding trait rather than state-marker status. Schizo-obsessives also exhibited a trend toward more motor tics emphasizing a neurological contribution to the disorder.ConclusionOur findings reveal a more severe attentional set-shifting deficit and neurological abnormality that may be fundamental to the neuro-cognitive profile of schizo-OCD. The clinical implications of these impairments merit further exploration in larger studies.
Subject(s)
Neuropsychological Tests/statistics & numerical data , Obsessive-Compulsive Disorder/diagnosis , Obsessive-Compulsive Disorder/psychology , Schizophrenia/diagnosis , Schizophrenic Psychology , Adult , Affect/physiology , Aged , Attention/physiology , Comorbidity , Corpus Striatum/physiopathology , Diagnosis, Differential , Diagnosis, Dual (Psychiatry) , Discrimination, Psychological/physiology , Executive Function/physiology , Female , Frontal Lobe/physiopathology , Humans , Male , Middle Aged , Nerve Net/physiopathology , Obsessive-Compulsive Disorder/physiopathology , Psychiatric Status Rating Scales/statistics & numerical data , Psychomotor Performance/physiology , Reaction Time/physiology , Schizophrenia/physiopathology , Semantics , Young AdultABSTRACT
The association between schizophrenia and obsessive-compulsive disorder (OCD) is complex. This study systematically examined a UK cohort of clozapine-treated individuals with schizophrenia/schizoaffective disorder. Fourteen of 59 cases (24%) scored positively on item H of the Mini-International Neuropsychiatric Interview (MINI) for OCD. The mean Yale- Brown Obsessive-Compulsive Scale (Y-BOCS) score in MINI-positive cases was 17.6 (SD+/-6.3). Sixty-four percent scored 16 or more on the Y-BOCS, representing clinically meaningful illness severity. Seven (50%) patients with OCD had previously received the diagnosis by their treating clinicians and were already receiving with selective serotonin re-uptake inhibitors (SSRIs) treatment. OCD cases scored significantly worse than their non-OCD counterparts on the Abnormal Involuntary Movement Scale (P=0.01) and the Simpson Angus Scale (SAS; P=0.01). There was also a non-significant trend toward higher ratings for OCD cases on the Clinical Global Impression-Schizophrenia scale (P=0.06). Comparing the OCD cases taking SSRI (n=7) with those not on SSRI (n=7), significant differences emerged on the SAS (P=0.03). Our results suggest that OCD is common among patients receiving clozapine for schizophrenic disorders and that the comorbidity is associated with greater motoric impairment. The role of medication in this condition remains unclear.
